
	Mr. Sujal Shah has been the Chief Financial Officer of Cymabay Therapeutics, Inc, since December 6, 2013. Mr. Shah served as Acting Chief Financial Officer of Cymabay Therapeutics from June 27, 2012 to December 6, 2013. From 2010 to 2012, Mr. Shah served as Director of Health Care Investment Banking Group for Citigroup. From 2004 to 2010 Mr. Shah served as a Vice President of Health Care Investment Banking Group for Credit-Suisse. Mr. Shah holds an MBA from Carnegie Mellon University - Tepper School of Business in 2004 and a MS from Northwestern University in Biomedical Engineering in 1997.
